(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, TX between December 3 rd – 6 th, 2024 was host to a prostate cancer session. Dr. John Davis discussed the ...
In November 2023, the United States Food and Drug Administration (FDA) approved enzalutamide, with or without concurrent leuprolide therapy, for non-metastatic hormone-sensitive prostate cancer (M0 ...
These case studies review the treatment of patients with overactive bladder (OAB), a chronic condition presenting with urinary urgency, often occurring with frequency and nocturia, which may or may ...
Urinary incontinence (UI) is an uncontrollable expulsion of urine at a time. UI is obviously not life-threatening, but its impact on the patient's quality of life (QoL) is often devastating. Many ...
Comparing Autologous and Mesh Slings for Stress Incontinence Efficacy and Safety - Ariana Smith ...
A systematic review and meta-analysis were performed to determine the association of metabolic syndrome (METS) in women with and without overactive bladder (OAB). PRISMA guidelines were followed and ...
Urinary incontinence (UI), particularly urge urinary incontinence (UUI), is a prevalent condition that worsens with age and negatively affects quality of life. Antioxidants, measured by the composite ...
In the past few years, the urothelial carcinoma (UC) treatment landscape has been revolutionized by targeted therapies, immunotherapy, and antibody-drug conjugates (ADCs). Aberrant expression of ...
Obstructive sleep apnea has been associated with various urinary system diseases, including prostatic hyperplasia and nocturia. Recently, it has been linked to prostate cancer. This study investigated ...
This study aimed to analyze the clinical efficacy and safety of autologous fascial pubovaginal sling (AFPVS) surgery in treating recurrent stress urinary incontinence (SUI) following the failure of ...
While pump manipulation is rarely problematic in male patients with artificial urinary sphincters (AUSs), the situation may differ in female patients due to anatomical or cultural factors. This study ...
Approximately 75% of bladder cancer cases are non-muscle invasive at diagnosis. Drug development for non-muscle invasive bladder cancer (NMIBC) has historically lagged behind that of other ...